MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3DR; BREAST - ABSORBABLE MESH

Model Number	100043-04
Medical Device Problem Code	Migration or Expulsion of Device (1395)
Health Effect - Clinical Codes	Capsular Contracture (1761); Unspecified Reproductive System or Breast Problem (4513)
Date of Event	11/27/2018
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Based on the information provided, no conclusions can be made.As reported, the patient experienced the post-op complication of migration, malposition and capsular contracture.Medical affairs has assessed the patient¿s postoperative course migration, malposition and capsular contracture as being serious and likely related to the study device.Review of the device history records confirmed the device was manufactured to specification.Migration is a known inherent risk of the surgery/use of the device and listed as a possible complication in the adverse reaction section of the instructions for use (ifu) supplied with the device.This mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr.All safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness.In an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.
Event or Problem Description
Per clinical trial (b)(6): on (b)(6) 2018, patient underwent revision left inferior breast capsulorrhaphy using a crescent/peri-areolar incision.Unknown if concomitant procedure(s) were done.1 piece of galaform (galaflex 3dr) was used - left side only.On (b)(6) 2018, left migration, malposition, or contraction was reported - inferior malposition.On (b)(6) 2019, patient had left breast capsulorrhaphy with capsular flap procedure.No end date was given.On (b)(6) 2019, left breast reoperation was reported (left breast was much lower than right).Patient had revision left breast capsulorrhaphy on (b)(6) 2019.Resolved without sequelae on (b)(6) 2019.Review by medical affairs identifies the reported events migration, malposition, or contraction and reoperation are likely related to the device and serious.

• Brand Name: GALAFLEX 3DR
• Common Device Name: BREAST - ABSORBABLE MESH
• Manufacturer (Section D): TEPHA, INC. - 3005670760; 99 hayden ave suite 360; lexington MA 02421
• Manufacturer (Section G): TEPHA, INC. - 3005670760; 99 hayden ave suite 360; lexington MA 02421
• Manufacturer Contact: andrew topoulos ; 100 crossings blvd.; warwick, RI 02886 ; 8005566756
• MDR Report Key: 14938407
• Report Number: 1213643-2022-00495
• Device Sequence Number: 6357737
• Product Code: OOD
• UDI-Device Identifier: 00855920006256
• UDI-Public: (01)00855920006256
• Combination Product (Y/N): N
• Initial Reporter State: NC
• Initial Reporter Country: US
• PMA/510(K) Number: K162922
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Reporter Type: Manufacturer
• Report Source: Other,Study
• Initial Reporter Occupation: Physician
• Type of Report: Initial
• Report Date (Section B): 06/29/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 03/11/2019
• Device Model Number: 100043-04
• Device Catalogue Number: FR3D04
• Device Lot Number: 180084
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Initial
• Initial Date Received by Manufacturer: 06/28/2022
• Initial Report FDA Received Date: 07/06/2022
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 04/11/2018
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 36 YR
• Patient Sex: Female
• Patient Weight: 60 KG